Completed PHASE3 INTERVENTIONAL 4-arm NCT00193856

RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

A Randomised Trial Investigating the Effect on Biochemical (PSA) Control and Survival of Different Durations of Adjuvant Androgen Deprivation in Association With Definitive Radiation Treatment for Localised Carcinoma of the Prostate.

Sponsor: Abbott

Conditions Prostate Cancer

Interventions Conventional external beam therapy Leuprorelin Acetate Zoledronic Acid

Updated 7 times since 2017 Last updated: Oct 10, 2017 Started: Oct 31, 2003 Primary completion: Aug 31, 2017 Completion: Aug 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00193856, this PHASE3 trial focuses on Prostate Cancer and remains completed. Sponsored by Abbott, it has been updated 7 times since 2003, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Oct 2017 — Jun 2018 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed

▶ Show 2 earlier versions

Feb 2017 — Oct 2017 [monthly]

Active Not Recruiting PHASE3
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE3

First recorded

Oct 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott
Calvary Mater Newcastle, Australia
Cancer Society of New Zealand
Health Research Council, New Zealand
Hunter Medical Research Institute (HMRI)
Maitland Cancer Appeal
National Health and Medical Research Council, Australia
Novartis Pharmaceuticals
Trans Tasman Radiation Oncology Group
University of Newcastle, Australia

Data source: Trans Tasman Radiation Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Auckland, New Zealand , Campbelltown, Australia , Christchurch, New Zealand , Dunedin, New Zealand , East Melbourne, Australia , Geelong, Australia , Hamilton, New Zealand , Herston, Australia , Kogarah, Australia , Launceston, Australia and 14 more locations